Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 801–900 of 1,004
Qiu, L., Wang, T., Xu, X., Wu, Y.-H., Tang, Q., & Chen, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122505 · Cited by 44
“Signaling pathways, such as TGF-β and Wnt/β-catenin pathway, also contribute to EMT and subsequently metastasis [49,50].”
BackgroundInfluentialYang, X., Wang, L., Wang, Q., Li, L., Fu, Y., & Sun, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.170 · Cited by 46
Liao, S., Yu, C., Liu, H., Zhang, C., Li, Y., & Zhong, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s185156 · Cited by 46
“EMT refers to a change from epithelial cell morphology to mesenchymal morphology, including loss of cell polarity and increase of migratory capacity.(19) E-cadherin, N-cadherin, and vimentin are classical biomarkers of EMT.”
BackgroundHo, K., Cheng, C., Chou, C., Chen, P., Liu, A.-J., Lin, C., Shih, C.-M., & Chen, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104390 · Cited by 48
Zeng, Q., Liu, Y., Liu, J., Han, J., Guo, J., Lu, S., Huang, X., Yi, P., Lang, J., Zhang, P., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1807-7 · Cited by 44
Wang, Y., Cao, P., Alshwmi, M., Jiang, N., Xiao, Z., Jiang, F., Gu, J., Wang, X., Sun, X., & Li, S. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s208781 · Cited by 46
LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells
Cebrià‐Costa, J. P., Pascual‐Reguant, L., González-Pérez, A., Serra‐Bardenys, G., Querol, J., Cosín, M., Verde, G., Cigliano, R. A., Sanseverino, W., Segura‐Bayona, S., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0969-1 · Cited by 52
Evolving functions of Dickkopf-1 in cancer and immunity
Jaschke, N., Hofbauer, L. C., Göbel, A., & Rachner, T. D. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.03.031 · Cited by 52
CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations
Gomari, M. M., Farsimadan, M., Rostami, N., Mahmoudi, Z., Fadaie, M., Farhani, I., & Tarighi, P. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108374 · Cited by 44
Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers
Davoodvandi, A., Farshadi, M., Zare, N., Akhlagh, S. A., Nosrani, E. A., Mahjoubin‐Tehran, M., Kangari, P., Sharafi, S. M., Khan, H. Z., Aschner, M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668567 · Cited by 50
Song, J., Lin, Z., Liu, Q., Huang, S., Han, L., Fang, Y., Zhong, P., Dou, R., Xiang, Z., Zheng, J., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.992 · Cited by 47
Transforming growth factor-β in tumour development
Trelford, C. B., Dagnino, L., & Guglielmo, G. M. D. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.991612 · Cited by 49
“EMT is involved in the ability of carcinoma cells to acquire motile and invasive phenotypes, thus contributing to tumour progression and metastasis (Craene and Berx, 2013).”
BackgroundXu, H., Wang, J., Al‐Nusaif, M., Ma, H., & Le, W. (2023) · Cell Proliferation · doi:10.1111/cpr.13560 · Cited by 43
“13 Besides, growing evidence suggests that autophagy is vital in tumour metastasis.”
BackgroundA novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome
Soundararajan, R., Paranjape, A. N., Barsan, V. V., Chang, J. T., & Mani, S. A. (2015) · Scientific Reports · doi:10.1038/srep11766 · Cited by 46
Fujii, T., Shimada, K., Tatsumi, Y., Tanaka, N., Fujimoto, K., & Konishi, N. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22381 · Cited by 43
“process; TGF-b is a major inducer of EMT in several cancer cell types, acting either alone or in combination with cytokines or growth factors [34].”
BackgroundDong, S., Kong, J., Kong, F., Kong, J., Gao, J., Ji, L., Pan, B., Chen, L., Zheng, L., & Sun, W. (2015) · BMC Cancer · doi:10.1186/s12885-015-1949-7 · Cited by 43
“Epithelial-mesenchymal transition (EMT) is a complex process, involving dissolution of cell-cell junctions and loss of apical-basolateral polarity, resulting in transition of epithelial cells into migratory mesenchymal cells with invasive properties [13].”
Kim, S., Gwak, H., Kim, H. S., Kim, B., Dhanasekaran, D. N., & Song, Y. S. (2016) · Oncotarget · doi:10.18632/oncotarget.13074 · Cited by 43
Chen, W., Zhao, K., Miao, C., Xu, A., Zhang, J., Zhu, J., Su, S., & Wang, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s130139 · Cited by 43
Wu, J., Weng, Y., He, F., Liang, D., & Cai, L. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000626 · Cited by 45
CTCs 2020: Great Expectations or Unreasonable Dreams
Rossi, E. M. C., & Fabbri, F. (2019) · Cells · doi:10.3390/cells8090989 · Cited by 45
Rhein Suppresses Colorectal Cancer Cell Growth by Inhibiting the mTOR Pathway In Vitro and In Vivo
Zhang, H., Yi, J. K., Huang, H., Park, S., Park, S., Kwon, W., Kim, E., Jang, S., Kim, S., Choi, S., et al. (2021) · Cancers · doi:10.3390/cancers13092176 · Cited by 43
“The primary antibodies PI3K, p-Akt, Akt, p-mTOR, mTOR, cleaved caspase3, p53, p-p53, Bax, p70 S6 Kinase (p70S6K), p-p70 S6 Kinase (p-p70S6K), cyclin-dependent kinase (CDK) 2, cyclin D1, cyclin E1, E-cadherin, N-cadherin, Heat shock protein 90 (HSP90), 4EBP1, and p-4EBP1 were purchased from Cell Signaling Technology (B…”
BackgroundInfluentialThe Role of Tumor Stem Cell Exosomes in Cancer Invasion and Metastasis
Liu, K., Gao, X., Kang, B., Liu, Y., Wang, D., & Wang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836548 · Cited by 49
“Non-coding RNA, differential splicing, translation, and post-translational control mainly participate in the regulation of EMT (94).”
BackgroundInfluentialKoelzer, V. H., Huber, B., Mele, V., Iezzi, G., Trippel, M., Karamitopoulou, E., Zlobec, I., & Lugli, A. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.07.010 · Cited by 45
“Recent studies provide evidence that carcinomas undergo epithelial-mesenchymal transition in the tumor microenvironment leading to dissociative growth, migration, and invasion of the host vasculature [2].”
BackgroundKwon, H., Choi, M., Ahn, Y., Jang, D., & Pak, Y. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00546-2 · Cited by 45
Kovanecz, I., Gelfand, R., Masouminia, M., Gharib, S., Segura, D., Vernet, D., Rajfer, J., Li, D. K., Kannan, K., & Gonzalez-Cadavid, N. F. (2014) · International Journal of Impotence Research · doi:10.1038/ijir.2013.37 · Cited by 42
“Remarkably, EMT, a process that plays a pivotal role in wound healing, tissue regeneration and organ inflammation and fibrosis, as well as cancer (32,33,51), is affected by miR-203 as well as the considerably downregulated miRs -200 and -205, and by the lesser downregulated miRs-347, -377, and -494 (52–54).”
BackgroundYamamoto, S., Huang, D., Du, L., Korn, R. L., Jamshidi, N., Burnette, B., & Kuo, M. (2016) · Radiology · doi:10.1148/radiol.2016160259 · Cited by 46
Prasad, R., & Katiyar, S. K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_11 · Cited by 44
miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3
Wang, G., Fu, Y., Liu, G., Ye, Y., & Zhang, X. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14738114257367 · Cited by 42
Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer
Shen, K., Yu, W., Yu, Y., Liu, X., & Cui, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.016 · Cited by 47
Stability and mean residence times for hybrid epithelial/mesenchymal phenotype
Biswas, K., Jolly, M. K., & Ghosh, A. (2018) · Physical Biology · doi:10.1088/1478-3975/aaf7b7 · Cited by 42
“Recent experiments have identified key regulatory networks driving EMT [11].”
BackgroundMa, L., Zhai, B., Zhu, H., Li, W., Jiang, W., Lei, L., Zhang, S., Qiao, H., Jiang, X. L., & Sun, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0963-2 · Cited by 43
The oncogenic and tumor suppressive roles of RNA‐binding proteins in human cancers
Bitaraf, A., Razmara, E., Bakhshinejad, B., Yousefi, H., Vatanmakanian, M., Garshasbi, M., Cho, W. C. S., & Babashah, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30311 · Cited by 45
Ramamoorthi, G., Kodumudi, K. N., Gallen, C., Zachariah, N. N., Basu, A. B., Albert, G. K., Beyer, A., Snyder, C., Wiener, D. A., Costa, R. L. B., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.004 · Cited by 43
Volumetric compression develops noise-driven single-cell heterogeneity
Zhao, X., Hu, J., Li, Y., & Guo, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110550118 · Cited by 45
Migault, M., Sapkota, S., & Bracken, C. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04199-0 · Cited by 48
“Alternately, the phosphorylation of SNAI1 by PAK1 (p21 activated kinase 1) and ATM (ataxia telangiectasia mutated) kinases increase protein stability [14, 165, 166].”
BackgroundTeng, Y., & Xu, L. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9621-6 · Cited by 50
“Besides its significant role in physiological and developmental activities, EMT can also be reactivated in adults to achieve wound healing after tissue injury, and occurs in pathologies such as fibrosis or cancer progression [1, 2].”
BackgroundMeng, J., Han, J., Wang, X., Wu, T., Zhang, H., An, H., Qin, L., Sun, Y., Zhong, W., Yang, C., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106661 · Cited by 43
Yang, Y., Na, H. J., Suh, M. J., Ban, M., Byeon, H., Kim, W., Kim, J. W., Choi, E., Kwon, H., Chang, J., et al. (2015) · Yonsei medical journal · doi:10.3349/ymj.2015.56.6.1503 · Cited by 46
“The transition of an epithelial carcinoma to a mesenchymal phenotype (EMT) is characterized by immense morphologic changes marked by loss of polarity and cell-to-cell contacts, and an enhanced ability to migrate through the neighboring extracellular matrix.(8) The molecular hallmarks for EMT are downregulation of epit…”
BackgroundPlatelets, Cyclooxygenases, and Colon Cancer
Guillem‐Llobat, P., Dovizio, M., Alberti, S., Bruno, A., & Patrignani, P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.04.008 · Cited by 44
Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Yoo, M., Park, H. G., Han, S. I., & Kang, H. S. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2874 · Cited by 50
Xu, H.-X., Wu, K.-J., Tian, Y., Liu, Q., Han, N., He, X.-L., Yuan, X., Wu, G. S., & Wu, K.-M. (2016) · Medicine · doi:10.1097/md.0000000000004085 · Cited by 43
“2D) was increased in breast cancer tissues when compared with normal breast tissues.”
BackgroundZoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma
Kim, E. H., Kim, M., Lee, K.-H., Koh, J., Jung, W., & Kong, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12281 · Cited by 42
“The EMT process has been shown to play a critical role in promoting metastasis in carcinoma [26, 27].”
The Many-Faced Program of Epithelial–Mesenchymal Transition: A System Biology-Based View
Domenico, S. D., & Vergara, D. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00274 · Cited by 43
“There is now evidence that the expression of EMT biomarkers is temporally and spatially coordinated through the activation of a network of transcriptional factors (EMT-TFs) including Prxx1, Snail, Slug (Snail2), Twist, Zeb1, and Zeb2 that initiates and orchestrates the EMT program (39).”
BackgroundDermani, F. K., Amini, R., Saidijam, M., Pourjafar, M., Saki, S., & Najafi, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26874 · Cited by 45
“ZEB1, as the main transcription factor, inhibits E‐cadherin expression and triggers the EMT process (de Craene & Berx, 2013).”
BackgroundRetractedXue, Y., Yu, B., Liu, Y., Guo, R., Li, J., Zhang, L., Su, J., Sun, L., & Li, Y. (2019) · The Prostate · doi:10.1002/pros.23772 · Cited by 41
“At the same time, it can also bind to the promoter region of the gene encoding N-cadherin, CDH2, and increase its transcription.(10) Thus, TWIST1 is a vital EMT sensor and reports suggest that it could be an important potential target for cancer treatment.”
BackgroundNiu, W., Xu, L., Li, J., Zhai, Y., Sun, Z., Shi, W., Jiang, Y., Ma, C., Lin, H., Guo, Y., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11839 · Cited by 41
“…exposure to PPII significantly inhibited bladder cancer cell invasion and migration by regulating the expression of EMT-associated proteins and MMPs. EMT is a key step in cancer metastasis characterized by high expression of mesenchymal markers and low expression of epithelial markers (27,28).”
Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
Qiu, Y., Li, X., He, X., Pu, J., Zhang, J., & Lu, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112764 · Cited by 45
Che, F., Xie, X., Wang, L., Su, Q., Jia, F., Ye, Y., Zang, L., Wang, J., Li, H., Quan, Y., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.020 · Cited by 41
Yang, X., Cheng, Y., Zhou, J., Zhang, L., Li, X., Wang, Z., Yin, S., Zhai, L., Huang, T., Wu, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202104472 · Cited by 49
Epanchintsev, A., Shyamsunder, P., Verma, R. S., & Lyakhovich, A. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22240 · Cited by 40
“TNF-a and IL1beta are known inducer of the epithelial mesenchymal transition (EMT) [15–17], a process consisting of a gainofmotility and invasiveness by epithelial cells via disruption of cell-to-cell contacts, loss of cell polarity and cytoskeletal reorganization [18].”
BackgroundLi, F., Zou, Z., Suo, N., Zhang, Z., Wan, F., Zhong, G., Qu, Y., Ntaka, K. S., & Tian, H. (2014) · Medical Oncology · doi:10.1007/s12032-014-0180-8 · Cited by 42
“For instance, E-cadherin was down-regulated, while the Slug, Vimentin and N-cadherin were up-regulated.”
BackgroundInfluentialSlug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression
Zhao, X., Sun, B., Sun, D., Liu, T., Che, N., Gu, Q., Dong, X., LI, R., Liu, Y., & Li, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3562 · Cited by 40
Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways
Somarelli, J. A., Schaeffer, D., Marengo, M. S., Bepler, T., Rouse, D. C., Ware, K. E., Hish, A. J., Zhao, Y. C., Buckley, A. F., Epstein, J. I., et al. (2016) · Oncogene · doi:10.1038/onc.2015.497 · Cited by 43
“EMT is postulated to confer upon cancer cells the ability to detach from the primary tumor, degrade the basement membrane, and invade locally or distally (1, 2).”
Wei, Z., Ming-ling, T., Zhang, W., Han, G., Zhu, Z., Miao, Z., Li, J.-Y., & Qiao, Z. (2015) · PubMed Central · Cited by 40
Aspirin, platelets, and cancer: The point of view of the internist
Santilli, F., Boccatonda, A., & Davì, G. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.004 · Cited by 41
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma
Sneddon, S., Patch, A., Dick, I. M., Kazakoff, S. H., Pearson, J. V., Waddell, N., Allcock, R. J. N., Holt, R. A., Robinson, B. W. S., & Creaney, J. (2017) · BMC Cancer · doi:10.1186/s12885-017-3382-6 · Cited by 40
Missing Links in Epithelial-Mesenchymal Transition: Long Non-Coding RNAs Enter the Arena
Wang, L., Yang, F., Jia, L., & Yang, A. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485766 · Cited by 40
Li, W., Cho, M.-Y., Lee, S., Jang, M., Park, J., & Park, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220860 · Cited by 42
Ieda, T., Tazawa, H., Okabayashi, H., Yano, S., Shigeyasu, K., Kuroda, S., Ohara, T., Noma, K., Kishimoto, H., Nishizaki, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52816-z · Cited by 48
The P2X7 Receptor in the Maintenance of Cancer Stem Cells, Chemoresistance and Metastasis
Arnaud-Sampaio, V. F., Rabelo, I. L. A., Ulrich, H., & Lameu, C. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09936-w · Cited by 44
5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
Lee, Y., Cho, J.-M., Sai, S., Oh, J. Y., Park, J. A., Oh, S. J., Park, M., Kwon, J., Shin, U. S., Baek, J.-H., et al. (2019) · Cancers · doi:10.3390/cancers11121999 · Cited by 41
“EMT is critical for regulating the metastatic potentials [18].”
BackgroundCancer stem cells-driven tumor growth and immune escape: the Janus face of neurotrophins
Triaca, V., Carito, V., Fico, E., Rosso, P., Fiore, M., Ralli, M., Lambìase, A., Greco, A., & Tirassa, P. (2019) · Aging · doi:10.18632/aging.102499 · Cited by 43
“As a result, proteins of epithelial origin, like E-cadherin, are downregulated and N-cadherin, fibronectin, and vimentin are upregulated to facilitate cell motility and autonomy from niche signals [8, 94].”
BackgroundLi, X., Strietz, J., Bleilevens, A., Stickeler, E., & Maurer, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020404 · Cited by 41
“The EMT process is marked by morphological and genetic changes, in particular a dramatic change of EMT‐related factors [75].”
BackgroundSCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer
Shen, H., Huang, C., Wu, J., Li, J., Hu, T., Wang, Z., Zhang, H., Shao, Y., & Fu, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.656359 · Cited by 40
Cancer Cell Fusion and Post-Hybrid Selection Process (PHSP)
Hass, R., von der Ohe, J., & Dittmar, T. (2021) · Cancers · doi:10.3390/cancers13184636 · Cited by 40
Hou, J., Wang, T., Xie, Q., Deng, W., Yang, J. Y., Zhang, S. Q., & Cai, J.-C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.015 · Cited by 40
Han, I., Kim, J. H., Kim, S. S., Ahn, M., & Ryu, J. S. (2016) · Parasite Immunology · doi:10.1111/pim.12357 · Cited by 45
Liu, Y., Han, T., Wu, J., Zhou, J., Guo, J., Miao, R., Zhi, X., Xing, Y., Bai, Y., & Hu, D. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04616-3 · Cited by 54
“It is associated with various malignant features of tumors, including tumor initiation, cell migration, vascular infiltration, metastasis, and resistance to treatment [11–13].”
BackgroundManning, A. J., & Kimelman, D. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.09.001 · Cited by 49
“While a significant amount of work has investigated mechanisms underlying the various cellular processes that must be coordinated to initiate the EMT (Craene and Berx, 2013; Lamouille et al., 2014; Saunders and McClay, 2014), very little is known about late stages of this crucial developmental process when cells becom…”
BackgroundLai, D., Liu, S., Karlsson, A. I., Lee, W., Wang, K.-B., Chen, Y.-C., Shen, C.-C., Wu, S., Liu, C.-Y., Tien, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2307 · Cited by 40
Lv, H., Liu, R., Fu, J., Yang, Q., Shi, J., Chen, P., Ji, M., Shi, B., & Hou, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.947203 · Cited by 43
“E-cadherin is crucial in preventing the epithelial cells undergoing epithelial-tomesenchymal transitions, which denotes a cell reprogramming course during which epithelial cells acquire fibroblast-like properties and show reduced intercellular adhesion and enhanced migratory potential of tumor cells.(29) The PI3K/Akt…”
BackgroundPro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2
Mérino, D., Best, S. A., Asselin-Labat, M.-L., Vaillant, F., Pal, B., Dickins, R. A., Anderson, R. L., Strasser, A., Bouillet, P., Lindeman, G. J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.313 · Cited by 43
Lee, J., Byun, H.-J., Lee, M.-S., Jin, Y., Jeoung, D., Kim, Y., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.13767 · Cited by 39
“Key steps in malignant cancer progression are represented by the changes associated with epithelial-tomesenchymal transition (EMT) [14, 15].”
RPN11 deubiquitinase promotes proliferation and migration of breast cancer cells
Luo, G., Hu, N., Xu, X., Zhou, J., & Ye, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6587 · Cited by 41
“In EMT, cells lose their adhesion and epithelial features and switch to a mesenchymal phenotype, which is an indicator of cancer metastasis (26).”
Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer
Jin, Y., He, J., Du, J., Zhang, R., Yao, H., & Shao, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.6944 · Cited by 45
“The notch-signaling pathway is involved in the processes of tumor cell proliferation, invasion, and the establishment of a mesenchymal phenotype (33,34).”
Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development
Shi, Q., & Chen, Y. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9173-5 · Cited by 40
Qi, P., Lin, W.-R., Zhang, M., Huang, D., Ni, S., Zhu, X.-L., Bai, Q.-M., Sheng, W.-Q., Du, X., & Zhou, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s171652 · Cited by 39
“The EMT plays crucial roles in cancer initiation, progression, and particularly metastasis.(3,25,26) Accumulating data have revealed that lncRNAs regulate tumor metastasis by affecting the EMT.”
BackgroundBocci, F., Levine, H., Onuchic, J. N., & Jolly, M. K. (2019) · Current Stem Cell Reports · doi:10.1007/s40778-019-0150-3 · Cited by 39
Wang, S., Yan, S., Zhu, S., Zhao, Y., Yan, J., Xiao, Z., Bi, J., Qiu, J., Zhang, D., Hong, Z., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.08.004 · Cited by 39
Jolly, M. K., Ware, K. E., Xu, S., Gilja, S., Shetler, S., Yang, Y., Wang, X., Austin, R. G., Runyambo, D., Hish, A. J., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0763 · Cited by 41
“In carcinomas, the gene expression programs that control EMT/MET are regulated at multiple stages, including through epigenetics (10), transcription (11), miRNAs (12), alternative splicing (13, 14), and posttranslational protein stability (15).”
BackgroundMyc Regulation of a Mitochondrial Trafficking Network Mediates Tumor Cell Invasion and Metastasis
Agarwal, E., Altman, B. J., Seo, J. H., Bertolini, I., Ghosh, J. C., Kaur, A., Kossenkov, A. V., Languino, L. R., Gabrilovich, D. I., Speicher, D. W., et al. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00109-19 · Cited by 41
“chemotaxis (14), epithelial-mesenchymal transition (15), plasticity of circulating tumor cells (16), signaling from immune-inflammatory cells (17), and cues from the microenvironment (18).”
BackgroundAmirkhah, R., Naderi‐Meshkin, H., Shah, J. S., Dunne, P. D., & Schmitz, U. (2019) · Cells · doi:10.3390/cells8080929 · Cited by 42
“Epithelial to mesenchymal transition (EMT)-associated reprogramming of normal and tumour epithelial cells is a result of fundamental changes in several regulatory networks and the interplay between them [28].”
BackgroundWang, H., Lu, Y., Gong, Y., & Zhang, B. (2018) · Europe PMC (PubMed Central) · Cited by 57
Guereño, M., Pastore, M. D., Lugones, A. C., Cercato, M. C., Todaro, L. B., Urtreger, A. J., & Peters, M. G. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151096 · Cited by 44
Han, L., Wang, S., Wei, C., Fang, Y., Huang, S., Yin, T., Xiong, B., & Yang, C. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.13 · Cited by 42
p53 regulates cytoskeleton remodeling to suppress tumor progression
Araki, K., Ebata, T., Guo, A. K., Tobiume, K., Wolf, S. J., & Kawauchi, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1989-9 · Cited by 43
“Cancer cell invasion is frequently associated with disrupted cell–cell adhesion [22, 23].”
BackgroundZhou, S., Wang, Y., Yang, Y., He, Z., Zhao, R., Zhe, H., Zhang, X., Pan, S., Duan, W., Yang, T., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s73493 · Cited by 45
“It is a fine-tuned process regulated by a number of proteins that are strategically distributed in the nuclear and cytosolic compartments of cancer cells.(39) To further examine the mechanisms of the therapeutic effect of CDDO-Me on human ESCC cells, we evaluated the change of EMT-associated markers in Ec109 and KYSE7…”
BackgroundOvercoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem
Luqmani, Y. A., & Alam-Eldin, N. (2016) · Medical Principles and Practice · doi:10.1159/000444451 · Cited by 42
Zhong, G., Chen, L., Yin, R., Qu, Y., Bao, Y., Xiao, Q., Zhang, Z., Shen, Y., Li, C., Xu, Y., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6534 · Cited by 40
“Epithelial-mesenchymal transition (EMT) and chemotaxis are critical processes in cancer metastasis (1-3), and their interaction in cancer metastasis has been investigated in recent years.”
InfluentialDonato, M. D., Giovannelli, P., Migliaccio, A., & Castoria, G. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01008-4 · Cited by 42
LOXL2 in Cancer: A Two-Decade Perspective
Cano, A., Eraso, P., Mazón, M. J., & Portillo, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814405 · Cited by 46
p63 Attenuates Epithelial to Mesenchymal Potential in an Experimental Prostate Cell Model
Olsen, J. R., Oyan, A. M., Rostad, K., Hellem, M. R., Liu, J., Li, L., Micklem, D., Haugen, H., Lorens, J. B., Rotter, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062547 · Cited by 38
“investigaton has been done regarding putative epithelial transcription factors, but recently transcription factors responsible for maintaining and inducing the epithelial state, such as GRHL2, ELF3 and ELF5 have been acknowledged [11].”
BackgroundKučerová, L., Skolekova, S., Demková, L., Bohovic, R., & Matúšková, M. (2014) · Gene Therapy · doi:10.1038/gt.2014.66 · Cited by 39
Liu, G., Liu, Y., Lian, W., Zhao, Z., Yi, T., & Zhou, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3224 · Cited by 40
Liu, Y., Qian, J., Li, X., Chen, W., Xu, A., Zhao, K., Hua, Y., Huang, Z., Zhang, J., Liang, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12937 · Cited by 38
“A previous study reported that aberrant induction of EMT in cancer cells is related to malignant tumor behavior, such as enhanced migration, invasion, and metastasis capabilities [35].”
BackgroundThe long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma
Chung, I., Lu, P., Lin, Y.-H., Tsai, M.-M., Lin, Y.-W., Yeh, C., & Lin, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-00382-7 · Cited by 40
Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer
Chanda, A., Chan, A., Deng, L., Kornaga, E. N., Enwere, E. K., Morris, D. G., & Bonni, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177639 · Cited by 38
Werner, S., Stenzl, A., Pantel, K., & Todenhöfer, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55947-6_11 · Cited by 39
Bronte, G., Bravaccini, S., Bronte, E., Burgio, M. A., Rolfo, C. D., Delmonte, A., & Crinò, L. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12416 · Cited by 40
“This phenomenon leads to the progression and aggressiveness of various tumours (Rhim et al., 2012; De Craene & Berx, 2013; Yu et al., Biological Reviews 93 (2018) 1735–1746 © 2018 Cambridge Philosophical Society 2013).”
BackgroundHe, P., Qiu, K., & Jia, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-32737-z · Cited by 40
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.